drugset / Trial / NCT00004151
Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of acridine carboxamide in treating patients who have advanced non-small cell lung cancer that cannot be treated with surgery.
Timeline
- Start
- 1999-09
- Primary completion
- 2000-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | acridine carboxamide | Unknown | — | Intravenous |